0000-0001-7055-7056 About
I am currently working as a Research Assistant Professor at Ajman University, UAE. My current research focus is on therapeutic strategies targeting cancer and neurodegenerative disorders in terms of protein biochemistry and drug discovery. Cancer therapeutics research is largely focused on the identification of novel small molecules that can serve as potential leads in drug discovery. The focus of the group is finding potent and selective new therapeutic agents through the generation, integration, and translation of scientific knowledge. The other aspect of my work is studying the proteins that contribute to biological dysfunctions with a focus mainly devoted to cancer and Alzheimer’s disease. This domain provides an insight into cancer therapeutics and Alzheimer’s therapy. Another part of current research focuses on structure-based drug discovery.
Structure-based drug design has become a useful and essential part of the drug discovery and possibly the most relevant approach to discover bioactive leads exhibiting high specificity and effectiveness.
Employment
-
Ajman University Research Assistant Professor2025 - Present
-
Ajman University Full Time Researcher2022 - 2024
-
Jamia Millia Islamia D.S. Kothari Postdoctoral Fellow2020 - 2022
-
Jamia Millia Islamia NATIONAL POSTDOCTORAL FELLOW2018 - 2020
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (188)
- Dietary Polyphenols as Natural Modulators of NF‐κB Signaling in Inflammation‐Driven Non‐Communicable Diseases: Focus on Cancer Save
- Exploring drug repurposing for SGK1 inhibition: FDA-approved drugs and structural insights for new therapeutic strategies Save
- Network Biology of Alzheimer’s Disease and Related Neurodegenerative Disorders: Molecular Mechanisms and Therapeutic Strategies Save
- Neuroinflammaging and Sex-Specific Mechanisms: Biomarker Discovery and Emerging Technological Approaches in Aging Brain Disorders Save
- Identification of high-affinity inhibitors for epoxide hydrolase 2 from repurposed drugs in Parkinson’s disease therapeutics Save
- Structure‐Guided Identification and Evaluation of Epalrestat and Ranirestat‐Like Compounds Against Aldose Reductase: Therapeutic Management of Diabetic Neuropathy Save
- Applications of Genome Sequencing in Infectious Diseases: From Pathogen Identification to Precision Medicine Save
- Exploring TANK-Binding Kinase 1 in Amyotrophic Lateral Sclerosis: From Structural Mechanisms to Machine Learning-Guided Therapeutics Save
- The SPINK Protein Family in Cancer: Emerging Roles in Tumor Progression, Therapeutic Resistance, and Precision Oncology Save
- Interplay Between Aging and Tau Pathology in Alzheimer’s Disease: Mechanisms and Translational Perspectives Save